Shanghai, China

Jing Xue

This inventor holds 1 USPTO granted patent. Top assignee: Biointron Biological Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Xue. Retrieved from https://idiyas.com/inventor/jing-xue-ht06rrd7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jing Xue: Innovator in Antibody Development

Introduction

Jing Xue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Jing Xue holds a patent for an "ANTI-CD40 SINGLE-DOMAIN ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF." This patent highlights his focus on creating novel therapeutic agents that can potentially improve treatment options for various diseases.

Career Highlights

Jing Xue is currently employed at Biointron Biological Inc., where he continues to push the boundaries of research and development in the biotechnology sector. His work at the company has positioned him as a key player in the field, contributing to advancements that may have a lasting impact on healthcare.

Collaborations

Jing collaborates with talented individuals such as Jiwen Du and Yan Yang, who contribute to the innovative environment at Biointron Biological Inc. Their combined expertise fosters a culture of creativity and scientific inquiry.

Conclusion

Jing Xue's contributions to antibody development and his innovative spirit exemplify the potential of biotechnology to transform healthcare. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…